Market Capitalization of Kabra Drugs (KABRADG)
As of Sept. 18, 2026, Kabra Drugs (KABRADG) market capitalisation is ₹49.32 Cr ($5.48M), with 2.58 Cr shares outstanding at a current price of ₹19.08 on BSE, ranking 3716 out of 5367 companies by market cap in our screener. Kabra Drugs operates in the Healthcare sector and is classified as a Small Cap stock. Explore KABRADG value investing to estimate fundamental worth using multiple valuation models.
Market Cap History of Kabra Drugs (Last 10 Years)
KABRADG market capitalisation from year-end BSE closing prices over the last 10 years. View KABRADG annual price range for the annual high/low range and current price position.
End of Year Market Cap History — Kabra Drugs
KABRADG year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. For live price, earnings and the complete company profile, see KABRADG stock price BSE.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹49.32 Cr
$5.48M USD
|
₹19.08 | BSE | -37.55% |
| 2025 |
₹78.97 Cr
$8.77M USD
|
₹30.55 | BSE | +203.68% |
| 2024 |
₹26.00 Cr
$2.89M USD
|
₹10.06 | BSE | +86.64% |
| 2023 |
₹13.93 Cr
$1.55M USD
|
₹5.39 | BSE | - |